| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Conjugate | |
| Formulation | |
| Host | |
| Immunogen | Mouse IgG whole molecule |
| Isotype | |
| Product Type | |
| Reactivity | |
| Shipping | |
| Storage | |
| Target |
Features & Benefits
DyLight fluorescent dyes are a new family of dyes with improved brightness and photostability). They are better than or comparable to the best fluorescent dyes from other companies). The detection level of any fluorophore-antibody conjugate depends on brightness and photostability of the dye; antibody activity, specificity, and cross-reactivity; and the optimal moles of dye per antibody). A molar saturation curve vs fluorescence intensity, antibody activity, background level, and/or other parameters has been established for each dye to optimize the level of antibody detection and minimize background). DyLight fluorescent dyes are highly water soluble and remain fluorescent from pH 4 to pH 9).
Background
Abbkine secondary antibodies are available conjugated to enzyme, biotin or fluorophore for use in a variety of antibody-based applications including Western Blot, ImmunoHistoChemistry, ImmunoFluorescence, Flow Cytometry and ELISA. We offer high quality secondary antibodies from goat, rabbit and donkey sources for your each application. Serum adsorbed secondary antibodies are also available and are recommended for use with immunoglobulin-rich samples.
Others
The antibody reacts with whole molecule mouse IgG. It also reacts with heavy chains of mouse IgG, and light chains of all other mouse immunoglobulins. It has no reactivity on non-immunoglobulin serum proteins, while it may cross-react with immunoglobulins from other species.
TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression(A23910-12.658)
Author: Zhang, Yu, et al, Publication name: Journal of Experimental & Clinical Cancer Research, IF: 12.658
Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells(A23910-12.121)
Author: Liu X, Wang H, Zhao X, Luo Q, Wang Q, Tan K, Wang Z, Jiang J, Cui J, Du E, Xia L, Du W, Chen D, Xia L, Xiao S, Publication name: Nat Commun, IF: 12.121
NASP Promotes Triple-negative Breast Cancer Progression and Metastasis by Stabilizing YAP in a USP15-Dependent Way.(A23910-10.000)
Author: Zheng, Wenfang, et al., Publication name: International Journal of Biological Sciences, IF: 10.000
Platelet Membrane and miR-181a-5p Doubly Optimized Nanovesicles Enhance Cardiac Repair Post-Myocardial Infarction through Macrophage Polarization.(A23910-8.200)
Author: Liu, Dongyue, et al., Publication name: ACS Applied Materials & Interfaces, IF: 8.200
Exosomes derived from stem cells from apical papilla promote craniofacial soft tissue regeneration by enhancing Cdc42-mediated vascularization(A23910-6.7)
Author: Y Liu, X Zhuang, S Yu, Publication name: Stem Cell Research & Therapy, IF: 6.7
Characterization and chemoproteomic profiling of protein O-GlcNAcylation in SOD1-G93A mouse model.(A23910-6.400)
Author: Hao, Yi, et al., Publication name: Molecular Medicine, IF: 6.400
Exosomes derived from stem cells from apical papilla promote craniofacial soft tissue regeneration by enhancing Cdc42-mediated vascularization(A23910-5.116)
Author: Liu Y, Zhuang X, Yu S, Yang N, Zeng J, Liu X, Chen X, Publication name: Stem Cell Res Ther, IF: 5.116
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells(A23910-5)
Author: X Qiao, L Zhu, R Song, C Shang, Y Guo, Publication name: Translational Oncology, IF: 5
Bacillus thuringiensis cry toxin triggers autophagy activity that may enhance cell death(A23910-4.8)
Author: Y Yang, X Huang, W Yuan, Publication name: Pesticide Biochemistry and Physiology, IF: 4.8
Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge(A23910-4.29)
Author: Y Cao, L Gao, L Zhang, Publication name: Scientific Reports, IF:
The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial‐to‐Mesenchymal Transition.(A23910-4.200)
Author: Liu, Ruoyang, et al., Publication name: Journal of Cellular and Molecular Medicine, IF: 4.200
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p(A23910-4.1)
Author: L Li, R Ai, X Yuan, S Dong, D Zhao, X Sun, Publication name: Journal of Hepatocellular Carcinoma, IF: 4.1
Sevoflurane Aggravates Hypoxic-Ischemic Encephalopathy in Preterm Neonates via VGluT1 Upregulation and Myelinogenesis Impairment.(A23910-3.700)
Author: Qin, Minyang, et al., Publication name: Brain Research Bulletin, IF: 3.700
Lipopolysaccharide downregulates the osteo-/odontogenic differentiation of stem cells from apical papilla by inducing autophagy(A23910-3.69)
Author: S Lei, XM Liu, Y Liu, Publication name: Journal of Endodontics, IF: 3.69
In vitro evaluation of hydroxycinnamoyl CoA:quinate hydroxycinnamoyl transferase expression and regulation in Taraxacum antungensein relation to 5-caffeoylquinic acid production(A23910-3.2)
Author: Qun Liu, Lixiang Yao, Yachen Xu, et al, Publication name: Phytochemistry, IF: 3.2
Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1(A23910-3.07)
Author: X Jiang, D Li, G Wang, Publication name: Oncology Reports, IF: 3.07
Bacillus thuringiensis Cry toxin triggers autophagy activity that may enhance cell death(A23910-2.751)
Author: Yang Y, Huang X, Yuan W, Xiang Y, Guo X, Wei W, Soberón M, Bravo A, Liu K, Publication name: Pestic Biochem Physiol, IF: 2.751
Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition(A23910-2.379)
Author: W Zang, J Liu, F Geng, D Liu, S Zhang, Y Li, Y Pan, Publication name: PeerJ, IF: 2.379
TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression(A23910-1.70)
Author: Zhang Y, Huang Z, Li K, Publication name: Journal of Experimental & Clinical Cancer Research, IF: 1.70